Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioma Glioblastoma Multiforme”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Temporarily pausedNCT06325683
What this trial is testing

Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma

Who this might be right for
Progressive GlioblastomaRecurrent Glioblastoma
National Cancer Institute (NCI) 184
Not applicableUnknownNCT04359745
What this trial is testing

Improving Treatment of Glioblastoma: Distinguishing Progression From Pseudoprogression

Who this might be right for
Glioblastoma
Guy's and St Thomas' NHS Foundation Trust 500
Early research (Phase 1)Active Not RecruitingNCT03423628
What this trial is testing

Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Who this might be right for
Recurrent Glioblastoma MultiformePrimary Glioblastoma MultiformeBrain Neoplasms, Malignant+1 more
AstraZeneca 159
Early research (Phase 1)Ended earlyNCT00006773
What this trial is testing

Bortezomib in Treating Patients With Recurrent Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+3 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT00895180
What this trial is testing

Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Adult Glioblastoma Multiforme
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 80
Testing effectiveness (Phase 2)Study completedNCT03174197
What this trial is testing

Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGliosarcoma
M.D. Anderson Cancer Center 60
Not applicableUnknownNCT05556382
What this trial is testing

Glioblastoma Evaluation for Heterogeneity In RadioseNsitivity

Who this might be right for
Glioblastoma
Istituto Clinico Humanitas 30
Testing effectiveness (Phase 2)Looking for participantsNCT03175224
What this trial is testing

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Who this might be right for
Solid TumorsAdvanced CancerRenal Cancer+15 more
Apollomics Inc. 497
Not applicableLooking for participantsNCT07413796
What this trial is testing

Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transdermal Interrupted Sutures

Who this might be right for
Brain Tumor AdultBrain Tumor BenignMeningioma+2 more
Medical University of Warsaw 382
Testing effectiveness (Phase 2)UnknownNCT03212235
What this trial is testing

Hypofractionated Radiation Therapy for Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Instituto do Cancer do Estado de São Paulo 58
Testing effectiveness (Phase 2)UnknownNCT02663440
What this trial is testing

Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage Colony-stimulating Factor for Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Zhejiang Cancer Hospital 41
Early research (Phase 1)Study completedNCT00002824
What this trial is testing

Gene Therapy in Treating Patients With Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Abramson Cancer Center at Penn Medicine
Testing effectiveness (Phase 2)Study completedNCT00004024
What this trial is testing

Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma

Who this might be right for
Brain and Central Nervous System Tumors
Barbara Ann Karmanos Cancer Institute 60
Testing effectiveness (Phase 2)Looking for participantsNCT07501559
What this trial is testing

A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of JL15003 Injection in Patients With Recurrent Glioblastoma (rGBM)

Who this might be right for
Recurrent Glioblastoma Multiforme(GBM)
Jecho Biopharmaceuticals Co., Ltd. 40
Early research (Phase 1)Study completedNCT00354068
What this trial is testing

Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 65
Very early researchUnknownNCT04315584
What this trial is testing

FDG and FDOPA PET Demonstration of Functional Brain Abnormalities

Who this might be right for
Glioblastoma
University of Virginia 5
Not applicableStudy completedNCT02751138
What this trial is testing

Determination of Immune Phenotype in Glioblastoma Patients

Who this might be right for
Glioblastoma Multiforme
University of Ulm 100
Early research (Phase 1)Ended earlyNCT02864368
What this trial is testing

Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens

Who this might be right for
GlioblastomaGlioblastoma Multiforme
Eric Thompson, M.D. 27
Early research (Phase 1)Ended earlyNCT03332355
What this trial is testing

Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2

Who this might be right for
Glioblastoma MultiformeAnaplastic Astrocytoma
Vanquish Oncology, Inc. 18
Testing effectiveness (Phase 2)Ended earlyNCT02227576
What this trial is testing

Prevention of Thrombocytopenia in Glioblastoma Patients

Who this might be right for
ThrombocytopeniaGlioblastoma
University Hospital, Lille 20
Next Page